• Helus Pharma, formerly Cybin, co-founders Eric So and Paul Glavine left their executive and consulting roles effective October 26, 2026.
• Mark Lawson became independent board chair, bringing over 20 years of experience in private equity and investment banking.
• Former President and Executive Chairman Eric So was named chairman emeritus, an honorary title.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cybin Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001833141-26-000094), on November 06, 2026, and is solely responsible for the information contained therein.